Skip to main content
Veterinary Medicines

Vasotop P 2.5 mg tablets for dogs

Authorised
  • Ramipril

Product identification

Medicine name:
Vasotop P 2.5 mg tablets for dogs
VASOTOP P
Active substance:
  • Ramipril
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ramipril
    2.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA05
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Carton box containing three 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
  • Carton box containing one 15 mL HD polyethylene container containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
  • Carton box containing six 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • MSD Animal Health S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102900
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0245/003
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Norway
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 17/02/2025
Download

PuAR Vastotop P 2.5mg- 24-6.pdf

English (PDF)
Published on: 17/02/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."